Runx1-mediated regulation of osteoclast differentiation and function

Molecular Endocrinology

Volumn 28, Issue 4, 2014, Pages 546-553

  Soung, Do Y ^a   Kalinowski, Judith ^a   Baniwal, Sanjeev K ^b   Jacome Galarza, Christian E ^a   Frenkel, Baruch ^b   Lorenzo, Joseph ^a   Drissi, Hicham ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CALCITONIN RECEPTOR; CARBOXY TERMINAL TELOPEPTIDE; CATHEPSIN K; CD11B ANTIGEN; COLLAGEN TYPE 1; COLONY STIMULATING FACTOR 1; CRE RECOMBINASE; GELATINASE B; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN C FOS; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR RUNX1; INTEGRASE; RUNX1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MARROW CELL; BONE MASS; CELL FUNCTION; CELL FUSION; CELL SURFACE; CONTROLLED STUDY; CORTICAL BONE; FEMALE; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MALE; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; MULTINUCLEAR CELL; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRABECULAR BONE; ANIMAL; BONE; BONE DEVELOPMENT; CELL DIFFERENTIATION; GENE DELETION; METABOLISM; ORGAN SIZE; OSTEOBLAST; PATHOLOGY;

ANIMALS; ANTIGENS, CD11B; BONE AND BONES; BONE MARROW CELLS; BONE RESORPTION; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 2 SUBUNIT; GENE DELETION; INTEGRASES; MICE; ORGAN SIZE; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS;

EID: 84897936712     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2013-1305     Document Type: Article

References (32)

1. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003; 423: 337-342.
2. Arai F, Miyamoto T, Ohneda O, et al. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J Exp Med. 1999; 190: 1741-1754.
3. Jacquin C, Gran DE, Lee SK, Lorenzo JA, Aguila HL. Identification of multiple osteoclast precursor populations in murine bone marrow. J Bone Miner Res. 2006; 21: 67-77.
4. hi osteoclast precursors but is essential for mature osteoclast formation in TNFα-mediated inflammatory arthritis. J Bone Miner Res. 2004; 19: 207-213.
5. Teitelbaum SL. Bone resorption by osteoclasts. Science. 2000; 289: 1504-1508.
6. Lorenzo JA, Canalis E, Raisz LG. Metabolic bone disease. In: Kronenberg H, Melmed S, Polonsky KS, Larsen PR, eds. Williams Textbook of Endocrinology. 11 ed. Philadelphia, PA: Elsevier Sanders; 2008; 11.
7. Rachner TD, Khosla S, Hofbauer LC. Osteoporosis: now and the future. Lancet. 2011; 377: 1276-1287.
8. Shane E, Burr D, Ebeling PR, et al. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2010; 25: 2267-2294.
9. Khosla S, Burr D, Cauley J, et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2007; 22: 1479-1491.
10. Takayanagi H. Mechanistic insight into osteoclast differentiation in osteoimmunology. J Mol Med (Berl). 2005; 83: 170-179.
11. Lee J, Kim K, Kim JH, et al. Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation. Blood. 2006; 107: 2686-2693.
12. Smink JJ, Bégay V, Schoenmaker T, Sterneck E, de Vries TJ, Leutz A. Transcription factor C/EBPβ isoform ratio regulates osteoclastogenesis through MafB. EMBO J. 2009; 28: 1769-1781.
13. Zhao B, Takami M, Yamada A, et al. Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis. Nat Med. 2009; 15: 1066-1071.
14. Miyauchi Y, Ninomiya K, Miyamoto H, et al. The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis. J Exp Med. 2010; 207: 751-762.
15. Zhao B, Grimes SN, Li S, Hu X, Ivashkiv LB. TNF-induced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-J. J Exp Med. 2012; 209: 319-334.
16. Niki M, Okada H, Takano H, et al. Hematopoiesis in the fetal liver is impaired by targeted mutagenesis of a gene encoding a non-DNA binding subunit of the transcription factor, polyomavirus enhancer binding protein 2/core binding factor. Proc Natl Acad Sci USA. 1997; 94: 5697-5702.
17. Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH, Speck NA. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci USA. 1996; 93: 3444-3449.
18. Growney JD, Shigematsu H, Li Z, et al. Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood. 2005; 106: 494-504.
19. Lorsbach RB, Moore J, Ang SO, Sun W, Lenny N, Downing JR. Role of RUNX1 in adult hematopoiesis: analysis of RUNX1-IRESGFP knock-in mice reveals differential lineage expression. Blood. 2004; 103: 2522-2529.
20. Saltman LH, Javed A, Ribadeneyra J, et al. Organization of transcriptional regulatory machinery in osteoclast nuclei: compartmentalization of Runx1. J Cell Physiol. 2005; 204: 871-880.
21. Bai S, Zha J, Zhao H, Ross FP, Teitelbaum SL. Tumor necrosis factor receptor-associated factor 6 is an intranuclear transcriptional coactivator in osteoclasts. J Biol Chem. 2008; 283: 30861-30867.
22. Bai S, Kitaura H, Zhao H, et al. FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner. J Clin Invest. 2005; 115: 2742-2751.
23. Ferron M, Vacher J. Targeted expression of Cre recombinase in macrophages and osteoclasts in transgenic mice. Genesis. 2005; 41: 138-145.
24. Soung DY, Devareddy L, Khalil DA, et al. Soy affects trabecular microarchitecture and favorably alters select bone-specific gene expressions in a male rat model of osteoporosis. Calcif Tissue Int. 2006; 78: 385-391.
25. Jastrzebski S, Kalinowski J, Stolina M, et al. Changes in bone sclerostin levels in mice after ovariectomy vary independently of changes in serum sclerostin levels. J Bone Miner Res. 2013; 28: 618-626.
26. Soung do Y, Gentile MA, Duong le T, Drissi H. Effects of pharmacological inhibition of cathepsin K on fracture repair in mice. Bone. 2013; 55: 248-255.
27. Aguila HL, Mun SH, Kalinowski J, Adams DJ, Lorenzo JA, Lee SK. Osteoblast-specific overexpression of human interleukin-7 rescues the bone mass phenotype of interleukin-7-deficient female mice. J Bone Miner Res. 2012; 27: 1030-1042.
28. Yerges LM, Klei L, Cauley JA, et al. Candidate gene analysis of femoral neck trabecular and cortical volumetric bone mineral density in older men. J Bone Miner Res. 2010; 25: 330-338.
29. Huang G, Zhang P, Hirai H, et al. PU. 1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis. Nat Genet. 2008; 40: 51-60.
30. Lee SH, Rho J, Jeong D, el al. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat Med. 2006; 12: 1403-1409.
31. Kim K, Lee SH, Ha Kim J, Choi Y, Kim N. NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cellspecific transmembrane protein (DC-STAMP). Mol Endocrinol. 2008; 22: 176-185.
32. Lees RL, Heersche JN. Macrophage colony stimulating factor increases bone resorption in dispersed osteoclast cultures by increasing osteoclast size. J Bone Miner Res. 1999; 14: 937-945.